Karbapeneemid: erinevus redaktsioonide vahel

<ref name="okereke">{{cite journal |author=Okereke, C. S. |title= Advances in the use of carbapenem antibiotics in the management of serious bacterial infections in special patient populations. I: Safety and efficacy in children and elderly patients |journal= Current Therapeutic Research |volume= 61 |issue= 5|pages= lk. 289-320289–320 |year=2000 |month=May |pmid= |doi= 10.1016/S0011-393X(00)80020-X }}</ref>

<ref name="matthews">{{cite journal |author=Matthews, S. J., Lancaster, J. W. |title= Doripenem monohydrate, a broad-spectrum carbapenem antibiotic |journal= Clinical Therapeutics |volume= 31 |issue= 1|pages= lk. 42-6342–63 |year=2009 |month=January |pmid= |doi= 10.1016/j.clinthera.2009.01.013}}</ref>

<ref name="Hakimelahi">{{cite journal |author= Hakimelahi, G. H., Moosavi-Movahedia, A. A., Sabourya, A. A., Osetrovb, V., Khodarahmic, G. A., Shiad, K.-S. |title= The Carbapenem-based prodrugs. Design, synthesis, and biological evaluation of carbapenems |journal= European Journal of Medicinal Chemistry |volume= 40 |issue= 4|pages= lk. 339-349339–349 |year=2005 |month=April |pmid= |doi= 10.1016/j.ejmech.2004.11.002}}</ref>

<ref name="Jones">{{cite journal |author= Jones, R. N., Sadera, H. S., Fritsche, T. R. |title= Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various β-lactamase resistance mechanisms |journal= Diagnostic Microbiology and Infectious Disease |volume= 52 |issue= 1|pages= lk. 71-7471–74 |year=2005 |month=May |pmid= |doi= 10.1016/j.diagmicrobio.2004.12.008}}</ref>